Interested in a Career at Eutropics?

We are looking for energetic and highly skilled individuals who share our vision and can contribute to the practice of translational biology leading to the delivery of tools to help in the fight against cancer. Within a highly interactive working environment, we provide a unique opportunity to make a positive and lasting impact on the practice of medicine.

Our operations are based on the skillful execution of science with the ultimate goal of helping patients. Our robust business practices have established a goal-oriented culture that is centered on integrity-based service to our clients and colleagues.

Eutropics is an equal opportunity employer

Please send your resume and a cover letter to

Currently Accepting Applications for:

Senior Scientist, Biomarker Discovery, Diagnostic Assay Development

Eutropics is currently developing CLIA laboratory developed tests (LDTs) that provide novel readouts proven to correlate to cancer patient response to treatment. The most advanced of these tests is a companion diagnostic (CDx) to identify patients for a new treatment regime in acute myeloid leukemia (AML). Other diagnostic tests are being developed for commercial use in additional blood cancers as well as in solid tumors. Our platform is a novel approach to antibody biomarker discovery and development that can be applied to flow cytometry, immuno-fluorescence, and multiplexed quantitative immunohistochemistry (IHC) assay formats. The biomarker assay measurements are benchmarked against cell, xenograft, and patient response. Our biomarkers are used in ex vivo functional assays to provide CDx and complimentary diagnostic tests for guiding cancer treatments.

Job Summary

  • Lead development of next generation of functional and antibody-based diagnostic assay methodologies and provide input in clinical feasibility assessments from scientific & technical perspective.
  • Optimize immunophenotyping and biomarker readouts in flow cytometry in established preclinical and clinical models to correlate to drug response.
  • Serve the role of CLIA Technical Supervisor/Lab Director for processing of patient samples using established SOPs and LDTs.
  • Lead discovery and validation effort of new flow cytometry-based LDTs and CDx assays.
  • Contribute to relevant biomarker/CDx performance metrics and content in accordance with SOPs, CLIA/CAP, GLP, and/or other regulatory guidance as appropriate.
  • Prepare regulatory submission documents and maintain internal regulatory documents and SOPs.
  • Provide oversight of Ab biomarker discovery, using mAb, phage, and yeast display approaches.
  • Support development of next generation tests by guiding colleagues currently engaged in assay development, including collaborating with outside academic and commercial labs.

Job Requirements

  • PhD or equivalent in biochemistry/biomedical science/immunology/oncology and 4+ years in clinical/biotech/pharma industry
  • Minimum of 4 years of experience in clinical diagnostic assay development.
  • Minimum of 4 years of documented experience with patient sample testing in CLIA and/or GLP/GCP regulated environment(s).
  • Experience with antibody development and use of antibodies as biomarkers in IHC and IF platforms is preferred.
  • Experience with clinical trial protocols and FDA regulatory processes for drug and companion diagnostic development required.
  • Strong interpersonal and communication skills, ability to function well in team-based environment.


  • medical
  • stock option plan
  • plus retirement savings plans

Job Type: Full-time

Highly motivated and qualified candidates eager to apply these skills to help lead a high impact novel platform program are invited to submit their CV

Eutropics is an equal opportunity employer

Apply Today